![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Real Hotel Grp | LSE:RHG | London | Ordinary Share | GB00B3D2NR11 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.875 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:3247U James Reed & Partners PLC 17 November 2005 Reed Health Group plc - Offer Update Not for release, publication or distribution in or into the United States of America, Canada, Australia or Japan. Increased Cash Offers by Altium Capital Limited on behalf of James Reed & Partners plc for Reed Health Group plc ("Reed Health") James Reed & Partners plc ("JRP") announces that it has today acquired 10,849,816 Ordinary Shares in Reed Health at above the cash offer price of 55p per share contained in the offer document dated 10 November 2005 (the "Offer Document"). The price at which it acquired these shares is 57.5p per share. Since the offer period began, on 8 November 2005, JRP has purchased a total of 15,509,013 Ordinary Shares, representing approximately 26.0 per cent. of the issued share capital of Reed Health. In addition, JRP has received irrevocable undertakings to accept its Offers in respect of 34,919,248 shares in Reed Health, representing approximately 58.5 per cent. of the issued share capital of Reed Health. Therefore, JRP either owns, or holds irrevocable undertakings to accept its Offers over a total of 50,428,261 shares in Reed Health, representing, in aggregate, approximately 84.5 per cent. of the existing issued share capital of Reed Health. In accordance with Rule 6.2(b) of the Code, JRP confirms that it will shortly increase its cash offer to 57.5p per share (the "Increased Offer"). A full announcement will be made as soon as practicable. PRESS ENQUIRIES for James Reed & Partners plc: Smithfield Reg Hoare / Katie Hunt 020 7360 4900 This announcement and the Increased Offer should be read in conjunction with, and is subject to, the full terms and conditions set out in the Offer Document and the Forms of Acceptance. Terms used in this announcement shall have the same meaning as those in the Offer Document. The directors of James Reed & Partners (the "Directors") accept responsibility for the information contained in this announcement. To the best of the knowledge and belief of the Directors (who have taken all reasonable care to ensure that such is the case), the information contained herein is in accordance with the facts and does not omit anything likely to affect the import of such information. The release, publication or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in any such jurisdictions into which this announcement is released, published or distributed should inform themselves about and observe any applicable requirements. The Offers (including the Loan Note Alternative) will not be made, directly or indirectly, in, into or from the United States, or by use of the United States mails, or by any means or instrumentality (including, without limitation, facsimile transmission, telex, telephone or e-mail) of United States interstate or foreign commerce, or any facility of a national securities exchange of the United States, Canada, Australia or Japan. Accordingly, this announcement, copies of this announcement and any related documents are not being and must not be mailed or otherwise distributed or sent in, into or from the United States, Canada, Australia or Japan and persons receiving this document and any related documents (including custodians, nominees and trustees) must not mail or otherwise forward, distribute or send them in, into or from the United States, Canada, Australia or Japan. All Reed Health Shareholders (including nominees, trustees or custodians) who would, or otherwise intend to forward this announcement, should inform themselves about and observe any applicable requirement. Altium Capital Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively for James Reed & Partners as financial adviser within the meaning of the Rules of the Financial Services Authority and for no one else in connection with the Offers. Altium Capital Limited is not advising any other person or treating any other person as its client in relation thereto and will not be responsible to anyone other than James Reed & Partners for providing the protections afforded to clients of Altium Capital Limited, or for giving advice to any other person in relation to the Offers, the contents of this announcement or any other matter referred to herein. END This information is provided by RNS The company news service from the London Stock Exchange END OUPBRBRTMMBBBJA
1 Year Reed Health Chart |
1 Month Reed Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions